Eye

Fig. 2: Mean change from baseline in NEI VFQ-25 metrics at Month 12 (M12) and Month 24 (M24). | Eye

Fig. 2: Mean change from baseline in NEI VFQ-25 metrics at Month 12 (M12) and Month 24 (M24).

From: Evaluation of care with intravitreal aflibercept treatment for UK patients with diabetic macular oedema: DRAKO study 24-month real-world outcomes

Fig. 2: Mean change from baseline in NEI VFQ-25 metrics at Month 12 (M12) and Month 24 (M24).

Search

Advanced search

Quick links